Skip to main content
. 2020 Nov 3;50(7):1679–1690. doi: 10.3906/sag-2005-327

Table 1.

Viral vectors commonly used in gene therapy studies.

Viral vector Packaging capacity (kb) Features
Adenovirus ≤ 7.5 Transient expression in most of the cells, immunogenic.
Adeno-associated virus (AAV) ≤ 4 Long-term expression in dividing and non-dividing cells.
Herpes Simplex virus ≥ 30 Long-term expression in most of the cells; low toxicity.
Alphaviruses ≤ 7.5 Transient gene expression in most of the cells including neurons and glial cells; low immunogenicity.
Retrovirus 8 Long-term expression in dividing cells; genome integration.
Lentivirus 8 Long-term expression in both dividing and non-dividing cells; genome integration.